Literature DB >> 31939581

Vitamin D, vitamin D binding protein, vitamin D receptor levels and cardiac dysautonomia in patients with multiple sclerosis: a cross-sectional study.

Tülin Aktürk1, Yaşar Turan1, Nermin Tanik1, Müjgan Ercan Karadağ2, Hikmet Sacmaci1, Levent Ertugrul Inan1.   

Abstract

OBJECTIVES: Vitamin D is a pleiotropic steroid hormone that modulates the autonomic balance. Its deficiency has been described as an environmental risk factor for multiple sclerosis (MS). The aim of this study was to investigate the serum levels of vitamin D, vitamin D binding protein (VDBP) and vitamin D receptors (VDR) and to evaluate cardiac dysautonomia in MS patients due to bidirectional interaction between vitamin D and the autonomic nervous system.
METHODS: The current cross-sectional study was conducted on 26 patients with relapsing-remitting MS and on 24 healthy controls. Twenty-four-hour ambulatory blood pressure variability (BPV) was calculated and the participants were evaluated for orthostatic hypotension and supine hypertension. Serum levels of vitamin D, VDBP and VDR were measured.
RESULTS: The mean serum vitamin D level was significantly lower in MS patients than in controls (p = 0.044); however there was no significant difference in terms of VDR and VDBP levels between the groups. Supine hypertension and orthostatic hypotension were significant and the 24-hour systolic BPV was significantly decreased in patients with MS (p < 0.05) compared to controls. No correlation was found between vitamin D, VDBP and VDR with supine hypertension, orthostatic hypotension and systolic BPV values (p > 0.05). Also, there was a negative correlation between VDBP and the EDSS (p = 0.039, r = -0.406).
CONCLUSION: There was no correlation between orthostatic hypotension, supine hypertension and systolic BPV values and serum vitamin D, VDBP and VDR in MS patients. Future prospective studies with large number of patients may help us to better understand the relationship between vitamin D and the autonomic nervous system.

Entities:  

Year:  2019        PMID: 31939581     DOI: 10.1590/0004-282X20190182

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Reduction in circulating vitamin D binding protein in patients with multiple sclerosis.

Authors:  Zhila Maghbooli; Abolfazl Omidifar; Tarlan Varzandi; Tayebeh Salehnezhad; Mohammad Ali Sahraian
Journal:  BMC Neurol       Date:  2021-04-20       Impact factor: 2.474

Review 2.  Vitamin D Binding Protein (VDBP) and Its Gene Polymorphisms-The Risk of Malignant Tumors and Other Diseases.

Authors:  Dominika Rozmus; Alicja Ciesielska; Janusz Płomiński; Roman Grzybowski; Ewa Fiedorowicz; Natalia Kordulewska; Huub Savelkoul; Elżbieta Kostyra; Anna Cieślińska
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.